Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome
Keyword(s):
Antiplatelet medications such as clopidogrel and tirofiban (glycoprotien IIb/IIIa inhibitors) are associated with a reduction in mortality and morbidity and are therefore recommended in the treatment of acute coronary syndromes. Massive pulmonary haemorrhage is a rare complication of both clopidogrel and tirofiban. Pulmonary haemorrhage may easily be mistaken for acute pulmonary oedema, a condition commonly seen in patients with acute coronary syndrome. Physicians need to be aware of this diagnostic dilemma because early treatment increases the chances of patient survival.
2014 ◽
Vol 16
(suppl A)
◽
pp. A87-A94
◽
2019 ◽
Vol 84
◽
pp. 105826
◽
2004 ◽
Vol 3
(1)
◽
pp. 83-84
2005 ◽
Vol 150
(4)
◽
pp. 690-694
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 69
(11)
◽
pp. 1271
◽
Keyword(s):
2017 ◽
Vol 241
◽
pp. 70-75
◽
2017 ◽
Vol 69
(11)
◽
pp. 237